Davide Mauri - Concepedia

Author

Davide Mauri

Also Known As

D Mauri, D N Mauri, D. MAURI, D. Mauri, DAVIDE MAURI, Davide MAURI, Davide Mauri, Davide N Mauri, Davide N. Mauri, Mauri, D.

243

Publications

9.6K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Ioannina University of Ioannina University of Lausanne University Hospital of Bern Aristotle University of Thessaloniki

About

Davide Mauri is an author at University Hospital of Ioannina specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	3.1K
2	Public Health	4	4	71
3	Engineering	1	1	43
4	Health Sciences	1	1	49
5	Biostatistics	1	1	111

Davide Mauri

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome Joanna R. Groom, Susan L. Kalled, Anne H. Cutler, Journal of Clinical Investigation Clinical ImmunologyHumoral ResponseImmunologyPathologyImmune Dysregulation	2002	806
LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator Davide Mauri, Reinhard Ebner, Rebecca I. Montgomery, Immunity	1998	770
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome Joanna R. Groom, Susan L. Kalled, Anne H. Cutler, Journal of Clinical Investigation Clinical ImmunologyHumoral ResponseImmunologyImmune RegulationPathology	2002	701
Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer Manfred Kaufmann, Gϋnter von Minckwitz, E Mamounas, Annals of Surgical Oncology Surgical OncologyBreast OncologyMedicineCancer ManagementPrimary Breast Cancer	2011	481
Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine D Mauri-Hellweg, Florence Bettens, Davide Mauri, The Journal of Immunology	1995	348
Treatment of Toxic Epidermal Necrolysis With High-Dose Intravenous Immunoglobulins Christa Prins, Francisco A. Kerdel, R. Steven Padilla, Archives of Dermatology	2003	322
Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4 Thierry Roger, Céline Froidevaux, Didier Le Roy, Proceedings of the National Academy of Sciences Microbial PathogensInnate Immune SystemImmunologyAnti-tlr4 AntibodiesImmunotherapy	2009	266
T Cell Costimulation by the TNF Ligand BAFF Bertrand Huard, Pascal Schneider, Davide Mauri, The Journal of Immunology	2001	226
Evaluating novel agent effects in multiple‐treatments meta‐regression Georgia Salanti, Sofia Dias, Nicky J. Welton, Statistics in Medicine Surgical OncologyOncologyMeta-analysisOptimism BiasCancer Management	2010	111
Tumor Necrosis Factor Receptor-associated Factor (TRAF) 1 Regulates CD40-induced TRAF2-mediated NF-κB Activation Mariola Fotin‐Mleczek, Frank Henkler, Heike Glauner, Journal of Biological Chemistry ApoptosisImmunologyImmune RegulationCell DeathGreen Fluorescent Protein	2003	103

Page 1